We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.99B
AUM Growth
+$203M
Cap. Flow
+$168M
Cap. Flow %
2.8%
Top 10 Hldgs %
39.68%
Holding
189
New
63
Increased
26
Reduced
35
Closed
53

Top Sells

Rank Stock Value
1
BILL icon
BILL Holdings
BILL
+$177M
2
MSFT icon
Microsoft
MSFT
+$159M
3
ADI icon
Analog Devices
ADI
+$155M
4
WIX icon
WIX.com
WIX
+$149M
5
NFLX icon
Netflix
NFLX
+$149M

Sector Composition

Rank Sector Weight
1 Technology 25.93%
2 Consumer Discretionary 9.83%
3 Communication Services 8.66%
4 Healthcare 7.99%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
51
Mastercard
MA
$498B
$28M 0.47%
80,506
-207,102
-72% -$75.3M
DVN icon
52
CALL
Devon Energy
DVN
$51B
$24.9M 0.41%
700,000
-750,000
-52% -$21.3M
ABBV icon
53
AbbVie
ABBV
$471B
$24.8M 0.41%
+230,267
New +$26.3M
XBI icon
54
State Street SPDR S&P Biotech ETF
XBI
$9.97B
$24.5M 0.41%
+195,028
New +$25.1M
IS
55
DELISTED
ironSource Ltd.
IS
$23.1M 0.39%
2,123,003
-231,022
-10% -$2.29M
CCJ icon
56
CALL
Cameco
CCJ
$36.9B
$21.7M 0.36%
+1,000,000
New +$18.9M
EGGF.U
57
DELISTED
EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
EGGF.U
$21.6M 0.36%
2,186,246
-41,254
-2% -$409K
CVS icon
58
CVS Health
CVS
$138B
$21.2M 0.35%
250,000
+155,000
+163% +$13M
BILL icon
59
BILL Holdings
BILL
$4.7B
$19.9M 0.33%
74,622
-767,243
-91% -$177M
BIIB icon
60
Biogen
BIIB
$31.7B
$18.5M 0.31%
65,500
+24,900
+61% +$8.16M
REGN icon
61
Regeneron Pharmaceuticals
REGN
$73.2B
$18.2M 0.3%
30,020
+7,020
+31% +$4.36M
QQQ icon
62
PUT
Invesco QQQ Trust
QQQ
$439B
$17.9M 0.3%
+50,000
New +$18.4M
F icon
63
Ford
F
$62.6B
$15M 0.25%
+1,059,323
New +$14.4M
MCK icon
64
McKesson
MCK
$106B
$14.7M 0.25%
73,800
-34,000
-32% -$6.8M
WAVC.U
65
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
$14.6M 0.24%
+1,480,000
New +$14.7M
AVTR icon
66
Avantor
AVTR
$9.54B
$14.1M 0.24%
345,000
-226,200
-40% -$8.84M
ELV icon
67
Elevance Health
ELV
$83B
$14M 0.23%
+37,500
New +$14.3M
COR icon
68
Cencora
COR
$62.3B
$13.7M 0.23%
+115,000
New +$13.8M
HCA icon
69
HCA Healthcare
HCA
$90.8B
$13.3M 0.22%
+55,000
New +$13.4M
COIN icon
70
Coinbase
COIN
$43.4B
$12.5M 0.21%
+55,012
New +$13.5M
LH icon
71
Labcorp
LH
$25.6B
$12.2M 0.2%
50,634
+33,174
+190% +$8.36M
PFE icon
72
Pfizer
PFE
$144B
$12M 0.2%
+279,000
New +$12.4M
CCJ icon
73
Cameco
CCJ
$36.9B
$11.7M 0.2%
+538,302
New +$10.2M
BIIB icon
74
CALL
Biogen
BIIB
$31.7B
$11.3M 0.19%
40,000
SGEN
75
DELISTED
Seagen Inc. Common Stock
SGEN
$11M 0.18%
65,000
+13,000
+25% +$2.02M

Similar funds

PointState Capital's Q3 2021 Portfolio in Review

As of Q3 2021, PointState Capital held 189 positions worth $5.99B, up 3.5% from $5.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PointState Capital's Q3 2021 filing shows 63 new, 26 increased, 35 reduced and 53 closed positions. Its largest new stake was Booking.com: 1,324,875 shares worth $126M. The largest sale was BILL Holdings, an estimated $177M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • PointState Capital's largest Q3 2021 buy was Booking.com: 1,324,875 shares worth $126M.
  • PointState Capital added most to Meta Platforms (Facebook) in Q3 2021, an estimated $222M increase.
  • PointState Capital's biggest Q3 2021 reduction was BILL Holdings, cutting an estimated $177M.
  • PointState Capital fully exited Analog Devices in Q3 2021, selling an estimated $155M.
  • PointState Capital's ten largest holdings make up 40% of its $5.99B portfolio in Q3 2021.
  • PointState Capital opened 63 new positions and closed 53 in Q3 2021.
  • PointState Capital's portfolio value rose 3.5% quarter-over-quarter to $5.99B.

Based on PointState Capital's 13F filing for Q3 2021, filed 15 Nov 2021.